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Despite the great research effort placed during the last decades in HIV-1 study, still some 
aspects of its replication cycle remain unknown. All this powerful research has succeeded 
in developing different drugs for AIDS treatment, but none of them can completely remove 
the virus from infected patients, who require life-long medication. The classical approach 
was focused on the study of virus particles as the main target, but increasing evidence 
highlights the importance of host cell proteins in HIV-1 cycle. In this context, tetraspanins 
have emerged as critical players in different steps of the viral infection cycle. Through their 
association with other molecules, including membrane receptors, cytoskeletal proteins, 
and signaling molecules, tetraspanins organize specialized membrane microdomains 
called tetraspanin-enriched microdomains (TEMs). Within these microdomains, several 
tetraspanins have been described to regulate HIV-1 entry, assembly, and transfer between 
cells. Interestingly, the importance of tetraspanins CD81 and CD63 in the early steps of 
viral replication has been recently pointed out. Indeed, CD81 can control the turnover of 
the HIV-1 restriction factor SAMHD1. This deoxynucleoside triphosphate triphosphohy-
drolase counteracts HIV-1 reverse transcription (RT) in resting cells via its dual function as 
dNTPase, catalyzing deoxynucleotide triphosphates into deoxynucleosides and inorganic 
triphosphate, and as exonuclease able to degrade single-stranded RNAs. SAMHD1 has 
also been related with the detection of viral nucleic acids, regulating the innate immune 
response and would promote viral latency. New evidences demonstrating the ability of 
CD81 to control SAMHD1 expression, and as a consequence, HIV-1 RT activity, highlight 
the importance of TEMs for viral replication. Here, we will briefly review how tetraspanins 
modulate HIV-1 infection, focusing on the latest findings that link TEMs to viral replication.
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THe CeLLULAR PLASMA MeMBRAne AS THe FiRST 
MODULATOR OF Hiv-1 inFeCTiOn
HIV-1 virus belongs to Lentivirus within the RNA family Retroviridae. It carries two identical 
molecules of positive ssRNA that are converted to dsRNA intermediate by viral RNA-dependent 
DNA polymerase (reverse transcriptase). HIV genome encodes for 16 proteins participating in sev-
eral phases during the HIV life cycle, the structural polyproteins Gag [consisting of matrix, capsid, 
Abbreviations: ADAM, a disintegrin and metalloprotease; CA, capsid; dNTPs, deoxynucleotide triphosphates; ERMs, ezrin, 
moesin, and radixin; ICD, intracellular domain; MA, matrix MA; NC, nucleocapsid; NLS, nuclear localization signal; NPC, 
nuclear pore complex; PIC, pre-integration complex; PIP2, phosphatidylinositol 4,5-biphosphate; RT, reverse transcription; 
RTC, reverse transcription complex; TEMs, tetraspanin-enriched microdomains.
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nucleocapsid (NC), and p6 proteins], Pol (consisting of protease, 
reverse transcriptase, and integrase), and envelope (Env; gp120 
and gp41); regulatory proteins (Tat and Rev); and accessory 
proteins (Vif, Vpr, Vpu/Vpx, and Nef) (1).
The HIV-1 envelope glycoprotein (Env) facilitates viral 
attach ment and entry into host cells (2). Three spikes form the 
Env trimeric complex, each spike consisting of the associa-
tion of a gp120 subunit on the surface and a transmembrane 
gp41 molecule (3). Gp120 interacts with CD4, the cellular 
transmembrane receptor expressed on the membrane of the 
target cell; and this induces a conformational change in gp120 
that exposes new sites for co-receptor binding. There are two 
types of HIV-1 viruses regarding co-receptor preference, 
either CCR5 and/or CXCR4. After this second interaction, 
a hydrophobic region in gp41 is exposed and inserted into the 
plasma membrane, so that viral and cellular membranes get 
close enough to create the fusion pore (2, 4). Besides the recep-
tor and co-receptor, other cell surface molecules expressed on 
dendritic cells (DC) can act as attachment factors, although 
they do not trigger viral fusion. Most attachment factors are 
C-type lectins, or calcium-dependent glycan-binding proteins 
such as DC-SIGN, Siglec-1, mannose, langerin, or DCIR (5–7).
The plasma membrane is not a homogeneous surface but 
contains specialized microdomains that can be differentiated by 
their composition and function: lipid rafts, tetraspanin-enriched 
microdomains (TEMs), caveolae, and clathrin-coated pits 
(8, 9). Lipid rafts, enriched in cholesterol and saturated lipids 
with long hydrocarbon chains and hydroxylated ceramide 
backbones (10–12), provide an environment that favors the 
inclusion of oligomeric proteins such as flotillins and caveolins, 
or proteins with lipid modifications such as palmitoylation or 
GPI anchors (13–15). While lipid rafts properties rely mainly 
on their lipid content, TEMs are organized around protein– 
protein interactions nucleated by tetraspanins (9). Tetraspanins, 
a superfamily of ubiquitous four transmembrane proteins, 
laterally interact with other membrane molecules stablish-
ing specialized domains or platforms called TEMs. The most 
common partners of tetraspanins are integrins, proteins of the 
immunoglobulin superfamily, metalloproteinases, membrane 
receptors, and other tetraspanins (9). TEMs also include cho-
lesterol and gangliosides. Lipid–protein and protein–protein 
interactions are facilitated by multiple palmitoylation sites in 
both tetraspanins and their partners (16).
Given the complex structure of the plasma membrane, it is 
not surprising that the CD4 receptor and CCR5/CXCR4 co-
receptors are not randomly distributed on the cell surface, but 
show a controlled segregation pattern into defined membrane 
clusters (17). This enrichment in specialized microdomains has 
been also reported for attachment factors such as DC-SIGN, 
in the surface of DCs (18). Inclusion of HIV-1 receptors and 
co-receptors in lipid rafts, caveolae microdomains, or TEMs 
tightly regulate viral entry. Since the presence of cholesterol is a 
common feature of these different microdomains, its depletion 
or the use of antibodies that specifically recognize clustered 
cholesterol on the cell surface induces a reorganization of the 
plasma membrane, disrupts receptor clustering and membrane 
dynamics, and inhibits virus entry (19, 20). These antibodies do 
not appear to mask CD4 and CXCR4 interaction sites, but rather 
seem to affect CXCR4 membrane diffusion, triggering an excess 
of CD4-CXCR4 clustering, which prevents proper attachment 
of the viral envelope proteins (19). CD4 and CCR5 co-receptor 
interact with each other under basal conditions, and addition of 
gp120 protein bring them closer (17, 21). Tetraspanins CD81 
and CD82 also associate with the CD4 receptor on T-cells 
(22, 23), and gp120 attachment to CD4 induce co-clustering of 
CD81 (24). CD81 modulates CD4 dimerization and clustering, 
and it decreases CD4 ability to bind to gp120 (25). All these 
results support the notion that membrane microdomains are 
critical regulators of HIV-1 receptors diffusion, allowing proper 
clustering and efficient protein–protein interactions required 
for viral entry (26) (Figure 1B). Under resting conditions, lipid 
rafts and TEMs are mainly independent domains at the cell sur-
face, recognized by the presence of specific markers. However, 
after viral infection, Gag can induce the coalescence of the two 
types of domains (27).
Other studies suggest that these microdomains may also 
be important to regulate receptor recycling and trafficking to 
the plasma membrane. Thus, the tetraspanin CD63 regulates 
CXCR4 expression on the plasma membrane of T-lymphocytes 
and activated B  cells. Moreover, CD63 glycosylation sites are 
critical for the interaction with CXCR4 (28) and promote 
CXCR4 trafficking from the Golgi apparatus to late endosomes 
and lysosomes for its degradation (29, 30) (Figure 1B).
CYTOSKeLeTOn, A SeCOnD BARRieR 
FOR THe viRUS?
Successful HIV-1 entry and infection depends on two sequential 
events, proper clusterization of the CD4 receptor and co-receptors 
after viral attachment, and subsequent polymerization and 
depolimerization of the cortical F-actin meshwork beneath the 
plasma membrane.
Although the cortical actin web was first described as a 
barrier for viral entry (21) (Figure 1A), inhibition of the actin 
nucleation regulator ARP2/3 was shown to inhibit viral Env-
induced fusion, highlighting the importance of an early actin 
polymerization phase that stabilizes viral attachment and sub-
sequent fusion with the plasma membrane (31). In addition, the 
tetraspanin TSPAN7 has been recently identified as an effector 
of actin nucleation (32), necessary for the formation of actin-
rich dendrites in DCs that capture, present, and transfer viruses 
to T-lymphocytes (33), in the process called trans-enhancement 
or trans-infection (Figure 1A).
Gp120 binding to CXCR4 regulates actin dynamics through 
the switch off and on of the actin-binding protein cofilin (21), 
which is inactivated by LIMK-1-dependent phosphorylation, 
promoting actin polymerization and receptor clustering (34). 
LIMK-1 is activated by CXCR4 via two different pathways: 
the Rac1/PAK and the RhoA/ROCK pathways. The activation 
of the latter depends on filamin-A, an actin adaptor protein 
that binds to CD4, CXCR4, and CCR5 (35). Although the 
primary activator of both pathways has not been addressed 
yet, tetraspanins CD82 or CD81 could be good candidates. 
FigURe 1 | Continued
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FigURe 1 | Tetraspanin roles during HIV-1 infection. (A) Tetraspanins regulate transinfection of T-lymphocytes. Dendritic cells stablish contacts with T-lymphocytes 
during antigen presentation. HIV-1 takes advantage of immune synapses to enhance the infection of T-lymphocytes, the main target cells for the virus. This strategy 
is called trans-enhancement or transinfection and takes place through two different pathways. One involves the endocytosis of viral particles by DCs, which  
gives them access to endosomal compartments. As happens with exosomes, viral particles accumulate in multivesicular bodies that finally fuse with the plasma 
membrane releasing those particles together with exosomes into the intercellular space. The second pathway involves TSPAN7, which inhibits viral endocytosis  
and promotes formation of actin rich protrusions in DCs. In this scenario, viral particles are sequestered on the surface of these cells, allowing virus exposure and 
transfer to T-lymphocytes. (B) TEM regulation of HIV-1 entry. CD4 and co-receptors CCR5/CXCR4 segregate within tetraspanin-enriched microdomains (TEMs), 
which control their proper distribution and dynamics enhancing HIV-1 attachment efficiency and subsequent entry. CD63 regulates the expression of CXCR4 on  
the cell surface by stimulating its degradation through the lysosomal pathway. Env binding to its receptor and co-receptor brings them closer and triggers several 
intracellular pathways where actin polymerization is the main response. Active LIMK1 phosphorylates and inactivates cofilin, stimulating actin polymerization. 
Proteins such as moesin or α-actinin have a structural function as they link receptors and tetraspanins to the subcortical actin network. Other proteins such  
as drebrin control the stability of the actin web. TSPAN7 is also a positive regulator of actin polymerization, although the effectors downstream have not been 
addressed yet. (C) HIV-1 assembly occurs at TEMs. Viral protein Gag interacts with the inner leaflet of the plasma membrane via its myristoylation, which  
increases the affinity for cholesterol-enriched areas. Gag also interacts with the positively charged PIP2 and the inner loop of different tetraspanins such as  
CD81 and CD82. Gag induces CD9 clusterization. However, there is no direct evidence indicating an essential requirement for tetraspanins during HIV-1  
budding. Recruitment of all these components into restricted areas may involve the presence of the subcortical actin web for their stabilization, where talin  
and vinculin would act as a link. (D) HIV-1 reverse transcription (RT) is regulated by tetraspanins. SAMHD1 is a negative regulator of viral RT as it decreases  
the concentration of deoxynucleotide triphosphates available in the cell. CD81 regulates SAMHD1 activity by stimulating its degradation via proteasome. CD81 
depletion induces the relocalization of SAMHD1 inside early endosomes. ADAM-10 activity is regulated by tetraspanin TSPANC8 subfamily. The resulting  
intracellular domain when cleaved by a γ-secretase has been identified recently as a component of the PIC. When RT is completed, viral DNA is transported  
into the nucleus where it integrates in the cell genome.
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CD82 can interact with CD4 and regulates actin dynamics in 
both T-lymphocytes and cancer cells through the modulation 
of RhoA and Rac1 signaling (36, 37), while CD81 regulates Rac 
activity turnover (38).
Besides Rho GTPase activity, the membrane lipid phospha-
tidylinositol 4,5-biphosphate (PIP2) facilitates viral infection 
by controlling the activity of several actin-binding proteins 
(31). Among them, ERMs (ezrin, moesin, and radixin), whose 
activation requires the interaction with PIP2 at the plasma 
membrane (39). Gp120 binding to CD4 receptor activates 
moesin, which triggers the reorganization of subcortical F-actin 
and stimulates CD4-CXCR4 clustering in T-lymphocytes (40) 
(Figure 1B). However, other studies performed in Hela cells 
described moesin as a negative regulator of viral infection 
(41), through the control of microtubule stability that could 
affect viral transport to the nucleus (42, 43). Moesin also 
interacts directly with CD81, or indirectly with either CD9 
or CD81 through EWI-2, a TEM component member of the 
immunoglobulin family (44). EWI-2 is also linked to the actin 
cytoskeleton via α-actinin, an actin-binding protein negatively 
regulated by PIP2 that induces a restrictive conformation for 
HIV entry on the cortical actin network (45, 46). Another 
CXCR4 interactor, drebrin, stabilizes actin in a process 
dependent on the viral envelope, so that drebrin silencing 
increases HIV-1 entry again supporting the idea of a need for 
a later actin depolymerization step for viral access into the cell 
(47) (Figure 1B).
This later step of depolymerization is also promoted by CXCR4 
through the activation of cofilin via Gαi signaling (48). Alteration 
in the levels of gelsolin, another actin regulatory molecule, also 
impairs HIV-1 infection (49). In this stage, destabilization of 
the actin network at later phases of viral entry would provide 
access of the virus to microtubules, which will transport the 
RTC [reverse transcription (RT) complex] toward the nucleus 
(31, 50). Studies using nocodazole (an inhibitor of microtubule 
polymerization), or kinesin and dynein inhibitors delay HIV-1 
uncoating and promote the accumulation of viral particles far 
away from the nucleus. Kinesin and dynein may contribute to 
the uncoating process by applying opposite forces that could 
destabilize and disrupt the structure of the capsid while it travels 
through the cytoplasm (51).
Tetraspanins and the actin cytoskeleton are also crucial for 
DC-mediated trans-infection by which the virus is retained at or 
near the cell surface of a DC and transmitted to a T-lymphocyte 
via the close contact of both cells. TSPAN7 expressed in DCs 
is important for the formation of actin rich spikes that are 
able to retain viral particles on their surface (32) (Figure 1A). 
In addition, DCs can trap viral particles in large intracel-
lular vesicles staining for tetraspanins CD81 and CD63 (52), 
although these structures may not be completely closed and 
remain connected with the extracellular space allowing a quick 
release of viral particles (53) during DC–T cell contacts. The 
exosome secretion pathway has been proposed as an alternative 
transmission route between cells without fusion events. Indeed, 
HIV-1 can directly use the endosomal pathway to enter DCs 
and be thereafter released together with exosomes after the 
fusion of multivesicular bodies with the plasma membrane 
(54, 55) (Figure 1A). In addition, recent studies suggest that in 
top of that, exosomes from DC are loaded with molecules that 
could enhance viral replication and release, such as CCR5 or 
CXCR4, which facilitate T-lymphocyte infection, miRNAs or 
viral proteins, such as Nef (56).
Hiv-1 PROMOTeS PLASMA MeMBRAne 
ReMODeLing
Upon successful infection, HIV-1 virus can modify the cell 
surface of infected cells to facilitate the release of new viral 
particles. Vpu and Nef are the viral proteins involved in this 
modulation. Both of them can control CD4 expression at 
the cell surface by different mechanisms. Nef is synthesized 
during the early steps of the infection, interacting with the 
plasma membrane through myristoylation modifications and 
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with the C-terminal domain of the CD4 receptor (57, 58). 
Nef forms a complex with AP-2, promoting CD4 endocytosis 
and subsequent transport to the lysosomal pathway for its 
degradation (59). Nef can also control MHC-I levels to protect 
the infected cell from the immune system, by stimulating its 
endocytosis from the cell surface and by inducing its accu-
mulation at the trans-Golgi network (60). In contrast, Vpu 
is a transmembrane viral protein that is transcribed during 
the late steps of the viral cycle, blocking CD4 transport from 
the endoplasmic reticulum to the membrane and stimulating 
CD4 degradation by the endoplasmic-reticulum-associated 
protein degradation pathway (61).
Tetraspanins CD9, CD81, CD82, CD63, and CD231 are 
included in HIV-1 particles negatively regulating viral infectiv-
ity (62). How the virus regulates their inclusion into virions 
remains unknown, but it does not seem to be an uncontrolled 
process since L6, a transmembrane protein with similar topol-
ogy is excluded (62). Remarkably, HIV-1 viral proteins also 
control tetraspanin expression on the plasma membrane. Vpu 
and Nef downregulate a wide variety of tetraspanins induc-
ing their enrichment at the perinuclear region of the cell 
(63). T-lymphocytes from HIV-1 patients showed a reduced 
expression of CD82 and CD81 (64), while the expression of the 
latter was increased in B-lymphocytes (65). CD81 and CD82 
downregulation was attributed to Vpu, and to a lesser extent 
to Nef. Vpu was shown to directly bind CD81, stimulating 
its degradation by either the proteasome or the lysosomal 
pathways. Although CD82 does not directly interact with Vpu, 
the viral protein also drives its degradation, probably through 
the association with CD81 (63). Therefore, downregulation of 
tetraspanin expression seems to be essential for virus spread. In 
addition, CD81 and CD9 play a negative role in viral-induced 
syncytia formation (24).
Viral assembly and budding is driven by Gag polyprotein, 
which is formed by matrix (MA), capsid (CA), NC, p6 domains, 
and two spacer peptides, named SP1 and SP2 (66) (Figure 1C). 
The initial evidence that suggested that assembly takes place 
in specialized microdomains came from the presence of high 
levels of cholesterol and sphingolipids in the HIV-1 envelope 
(67–69). After synthesis in the cytoplasm, Gag interacts with 
two molecules of viral RNA through its NC domain (70). Gag 
association with the cell surface then is driven by a cluster of 
positive amino acids in the MA domain, with affinity for nega-
tively charged PIP2 in the inner leaflet of the plasma membrane. 
Myristoylation of the N-terminal region of the MA domain 
contributes to its association to membrane areas enriched in 
cholesterol and sphingolipids, like lipid rafts or TEMs (26, 70). 
Env and Gag colocalize with tetraspanins CD63, CD81, and 
CD9 at the plasma membrane of T-cells and direct coimmu-
noprecipitation of CD81 with Gag has been reported (68, 71) 
(Figure 1C). Moreover, in both T-cells and macrophages, there 
is a relocalization of CD63 from intracellular compartments to 
viral assembly sites; however, its depletion does not affect viral 
release (72) (Figure 1C). In macrophages, viral assembly takes 
place in vacuoles that originate from invaginations of the plasma 
membrane (73), and present focal-adhesion-like domains more 
abundant in cells infected with the virus (74). These domains 
are enriched in integrin β2, focal adhesion components, tetras-
panins CD9, CD53, CD81 and CD82, and in PIP2 and AP-2, 
common components of clathrin-coated pits (75). After the 
budding of new virions, Gag is processed by the viral protease 
into the mature proteins enabling the formation of the capsid 
that contains the viral RNA genome and the enzymes needed 
for its replication (10, 70).
Further studies will be required to clarify the specific role of 
tetraspanins during the assembly and budding of new virions. 
All existing evidences support that tetraspanins are located at 
the exit sites and are incorporated in newly formed virions; 
however, future research should decipher whether they are 
functionally important for the organization and recruitment of 
all the components needed for budding (10).
inTRACeLLULAR evenTS OF Hiv-1 
inFeCTiOn ARe SURPRiSingLY ALSO 
DePenDAnT On MeMBRAne 
MiCRODOMAinS
The binding to the viral receptor and co-receptor triggers an 
intracellular response that prepares the host cell for HIV-1 
RT. After the fusion of the viral and the cell membranes, the 
capsid of the virus is released into the cytoplasm. RT occurs in 
a complex called RTC (RT complex), which is formed by viral 
proteins (reverse transcriptase, integrase, matrix protein and 
Vpr), the RNA genome, and host proteins needed to complete 
the cDNA synthesis (3, 76, 77). When the RNA genome is com-
pletely transformed into cDNA, this complex, still composed 
by a combination of viral and cellular proteins, is named PIC 
(pre-integration complex) (78). One surprising component of 
the HIV-1 PIC is the intracellular domain of the transmembrane 
A Disintegrin And Metalloprotease-10 (ADAM10) (79); so, 
when ADAM10 expression is inhibited, a decrease in HIV-1 
RT has been reported (Figure 1D). Tetraspanins could be also 
involved in this event, since ADAM10 localization, trafficking, 
and substrate specificity is regulated by a subfamily of tetraspa-
nins characterized for having eight Cys residues in their large 
extracellular loops (TspanC8) (80) (Figure 1D).
The role of the RTC in the RT process and how the uncoat-
ing process takes place is still a matter of debate. The first 
theory, no longer accepted, proposed that the capsid was 
lost immediately after membrane fusion and viral entry (81). 
Many studies have proven that the capsid is required for the 
RT process since it may provide protection against the host 
cell defense, as well as anchorage for the needed host factors 
(76). Another theory proposes that uncoating takes place while 
the RTC gets to the nucleus. The third one, however, claims 
that the whole capsid might travel along the cytoplasm until 
it reaches the nuclear pore complex where it is disassembled 
(77). There are different pieces of evidence that show that 
the capsid remains stable for some time after viral entry, and 
mutations that increase or decrease the stability of the capsid 
all have a negative effect on HIV-1 infection (81). Most results 
suggest that uncoating may occur during HIV-1 RT (82), and 
it should not involve a complete breakdown of the capsid but 
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a progressive disassembly along the trip through the cytoplasm 
(77). Destabilization of its structure would allow the access 
of the nucleotides, and host proteins needed for the viral RT 
(83). Before nuclear entry, however, the core has to be disrupted 
as it is too large to cross the nuclear pore (82).
Interestingly, some data suggest that membrane-bound 
tetra spanins also regulate after-entry events in HIV-1 infection. 
CD63 has been shown to regulate HIV-1 RT, nuclear transport, 
and integration; however, the mechanisms involved remain 
unsolved (84–86). RT is also modulated by tetraspanin CD81, 
via the regulation of SAMHD1 expression (87). SAMHD1 is a 
deoxynucleoside triphosphate triphosphohydrolase that con-
trols the availability of deoxynucleotide triphosphates (dNTPs) 
through their conversion into deoxynucleoside and inorganic 
triphosphate (88). Recent studies have identified an additional 
role of SAMHD1 in DNA repair and genome stability (89, 90). 
Others suggest that it may also have RNase activity over ssRNA 
or DNA/RNA duplexes (91), although these later results remain 
controversial (92). Because of its relevance, the cell has devel-
oped several mechanisms for SAMHD1 regulation. Related to 
its quaternary structure (93), SAMHD1 monomers associate in 
dimers, and these dimers organize in tetramers. The organization 
of SAMHD1 monomers into the active tetrameric form depends 
on the presence of dNTPs for its stabilization (94). Regarding 
posttranslational modifications, SAMHD1 can be phosphoryl-
ated by cyclin A2/CDK1 at T592 after T cell activation (95), or by 
tyrosine kinases downstream IL-2 and IL-7 stimulation of CD4+ 
T cells (96). These modifications decrease its dNTPase activity, 
increasing viral RT (96). Acetylation at K405 has the opposite 
effect, stimulating SAMHD1 dNTPase activity, and promoting 
the transition from G1 into S phase in cancer cells (97). SAMHD1 
oxidation status is another important regulatory mechanism. 
Three different cysteines of the enzyme can be oxidized, chang-
ing the nucleotide binding site conformation, preventing its 
tetramerization and subsequent activation (98). SAMHD1 has a 
nuclear and cytoplasmic distribution (87, 99). Nuclear localiza-
tion is mainly determined by its NLS sequence (100), and the 
oxidation status seems to be critical for its accumulation in the 
cytoplasm (98). Once in the cytoplasm, tetraspanin CD81 seems 
to regulate the enzyme subcellular localization into endosomes 
(87) (Figure 1D).
SAMHD1 expression levels are also tightly regulated. 
Reduced levels of SAMHD1 increase the amount of dNTPs 
available for viral RT. Thus, SAMHD1 is a major regulator of 
HIV-1 infection as it restricts the availability of dNTPs neces-
sary for HIV-1 RT in resting monocytes, macrophages, CD4+ 
T  cells, and DC. HIV-2 virus, but not HIV-1, expresses an 
accessory protein called Vpx that tags SAMHD1 for its deg-
radation by the proteasome (93, 101). SAMHD1 interaction with 
the C-terminal domain of the tetraspanin CD81 also stimulates 
its proteasomal degradation. Depletion of CD81 abolishes 
SAMHD1 degradation, which is translocated into early endo-
somal compartments where it exerts its dNTPase activity (87) 
(Figure 1D). Although it is reported that HIV-1 downregulates 
CD81 expression at the cell surface (64), this event might only 
occur late in the viral cycle, after RT has been completed.
COnCLUDing ReMARKS
Tetraspanins are important regulators of HIV-1 cycle. They 
would have a dual role in HIV-1 infection. Tetraspanins would 
inhibit infectivity by actively participating in viral entry. They 
would modulate cell surface dynamics and the proper distribu-
tion of receptors and co-receptors, both in the host cell and in 
the viral membrane inhibiting viral entry and induced mem-
brane fusion (24, 62). In contrast, CD81 can enhance viral RT 
by promoting SAMHD1 degradation through the proteasome, 
thus increasing the availability of dNTPs in the host cell (87). 
These opposite functions concur with a first round of active 
viral entry and replication to produce new viral particles in 
the cell, followed by a second round of viral latency to avoid 
recognition by the immune system so it can persist within the 
organism (102). HIV-1 possesses the tools to control tetraspanin 
expression by the host cell, avoiding undesirable effects on viral 
infection. As important membrane organizers, tetraspanins 
regulate multiple cellular proteins that control the different 
steps of HIV-1 infection cycle, and thus represent an interesting 
target for the development of new drugs against viral infection. 
Finally, it has been reported that peptides against the intracel-
lular region of CD81 can block its activity over SAMHD1 and 
reduce viral RT (87). This result leaves open the possibility of 
using specific peptides against tetraspanins as an interesting 
strategy to restrict HIV-1 infection.
AUTHOR COnTRiBUTiOnS
HS wrote the manuscript and designed the figures. VR-P con-
ceived and edited the manuscript. SA commented and edited the 
manuscript. MY-M conceived and edited the manuscript. All 
authors read and approved the final manuscript.
ACKnOwLeDgMenTS
We thank Dr. Cabañas for critical reading of the manuscript.
FUnDing
This work was supported by grants BFU2014-55478-R; BIO2017-
86500-R; Fundación Ramón Areces and RYC-2012-11025 to 
MY-M; and was co-funded by Fondo Europeo de Desarrollo 
Regional (FEDER). HS was supported by a FPI-UAM Fellowship.
ReFeRenCeS
1. Engelman A, Cherepanov P. The structural biology of HIV-1: mecha-
nistic and therapeutic insights. Nat Rev Microbiol (2012) 10(4):279–90. 
doi:10.1038/nrmicro2747 
2. Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring 
Harb Perspect Med (2012) 2(8):a006866. doi:10.1101/cshperspect.a006866 
3. Li G, De Clercq E. HIV genome-wide protein associations: a review 
of 30 years of research. Microbiol Mol Biol Rev (2016) 80(3):679–731. 
doi:10.1128/MMBR.00065-15 
7Suárez et al. Tetraspanins in HIV-1 Replication
Frontiers in Immunology | www.frontiersin.org August 2018 | Volume 9 | Article 1811
4. Power RA, Davaniah S, Derache A, Wilkinson E, Tanser F, Gupta RK, 
et al. Genome-wide association study of HIV whole genome sequences val-
idated using drug resistance. PLoS One (2016) 11(9):e0163746. doi:10.1371/
journal.pone.0163746 
5. Kijewski SD, Gummuluru S. A mechanistic overview of dendritic cell- 
mediated HIV-1 trans infection: the story so far. Future Virol (2015) 10(3): 
257–69. doi:10.2217/fvl.15.2 
6. McDonald D. Dendritic cells and HIV-1 trans-infection. Viruses (2010) 
2(8):1704–17. doi:10.3390/v2081704 
7. Izquierdo-Useros N, Lorizate M, Puertas MC, Rodriguez-Plata MT, Zangger N, 
Erikson E, et  al. Siglec-1 is a novel dendritic cell receptor that mediates 
HIV-1 trans-infection through recognition of viral membrane gangliosides. 
PLoS Biol (2012) 10(12):e1001448. doi:10.1371/journal.pbio.1001448 
8. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell 
Biol (2000) 1(1):31–9. doi:10.1038/35036052 
9. Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-
Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell 
plasma membranes. Trends Cell Biol (2009) 19(9):434–46. doi:10.1016/j.
tcb.2009.06.004 
10. Ono A. Relationships between plasma membrane microdomains and 
HIV-1 assembly. Biol Cell (2010) 102(6):335–50. doi:10.1042/BC20090165 
11. Simons K, Sampaio JL. Membrane organization and lipid rafts. Cold Spring 
Harb Perspect Biol (2011) 3(10):a004697. doi:10.1101/cshperspect.a004697 
12. Simons K, Ikonen E. Functional rafts in cell membranes. Nature (1997) 
387(6633):569–72. doi:10.1038/42408 
13. Langhorst MF, Reuter A, Stuermer CA. Scaffolding microdomains and 
beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci (2005) 
62(19–20):2228–40. doi:10.1007/s00018-005-5166-4 
14. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 
(2007) 8(3):185–94. doi:10.1038/nrm2122 
15. Resh MD. Covalent lipid modifications of proteins. Curr Biol (2013) 
23(10):R431–5. doi:10.1016/j.cub.2013.04.024 
16. Yang X, Claas C, Kraeft SK, Chen LB, Wang Z, Kreidberg JA, et  al. Pal-
mitoylation of tetraspanin proteins: modulation of CD151 lateral interac-
tions, subcellular distribution, and integrin-dependent cell morphology. 
Mol Biol Cell (2002) 13(3):767–81. doi:10.1091/mbc.01-05-0275 
17. Baker AM, Saulière A, Gaibelet G, Lagane B, Mazères S, Fourage M, et al.  
CD4 interacts constitutively with multiple CCR5 at the plasma membrane 
of living cells. A fluorescence recovery after photobleaching at variable 
radii approach. J Biol Chem (2007) 282(48):35163–8. doi:10.1074/jbc.
M705617200 
18. Cambi A, de Lange F, van Maarseveen NM, Nijhuis M, Joosten B, 
van Dijk EM, et  al. Microdomains of the C-type lectin DC-SIGN are 
portals for virus entry into dendritic cells. J Cell Biol (2004) 164(1):145–55. 
doi:10.1083/jcb.200306112 
19. Beck Z, Balogh A, Kis A, Izsépi E, Cervenak L, László G, et  al. New 
cholesterol-specific antibodies remodel HIV-1 target cells’ surface and 
inhibit their in  vitro virus production. J Lipid Res (2010) 51(2):286–96. 
doi:10.1194/jlr.M000372 
20. Mañes S, del Real G, Lacalle RA, Lucas P, Gómez-Moutón C, Sánchez-
Palomino S, et al. Membrane raft microdomains mediate lateral assemblies 
required for HIV-1 infection. EMBO Rep (2000) 1(2):190–6. doi:10.1093/
embo-reports/kvd025 
21. Spear M, Guo J, Wu Y. The trinity of the cortical actin in the initiation of 
HIV-1 infection. Retrovirology (2012) 9:45. doi:10.1186/1742-4690-9-45 
22. Imai T, Kakizaki M, Nishimura M, Yoshie O. Molecular analyses of the 
association of CD4 with two members of the transmembrane 4 superfamily, 
CD81 and CD82. J Immunol (1995) 155(3):1229–39. 
23. Imai T, Yoshie O. C33 antigen and M38 antigen recognized by monoclonal 
antibodies inhibitory to syncytium formation by human T  cell leukemia 
virus type 1 are both members of the transmembrane 4 superfamily and 
associate with each other and with CD4 or CD8 in T cells. J Immunol (1993) 
151(11):6470–81. 
24. Gordón-Alonso M, Yañez-Mó M, Barreiro O, Alvarez S, Muñoz-Fernández MA, 
Valenzuela-Fernández A, et  al. Tetraspanins CD9 and CD81 modulate 
HIV-1-induced membrane fusion. J Immunol (2006) 177(8):5129–37. 
doi:10.4049/jimmunol.177.8.5129 
25. Fournier M, Peyrou M, Bourgoin L, Maeder C, Tchou I, Foti M. CD4 
dimerization requires two cysteines in the cytoplasmic domain of the 
molecule and occurs in microdomains distinct from lipid rafts. Mol Immunol  
(2010) 47(16):2594–603. doi:10.1016/j.molimm.2010.06.010 
26. Florin L, Lang T. Tetraspanin assemblies in virus infection. Front Immunol 
(2018) 9:1140. doi:10.3389/fimmu.2018.01140 
27. Hogue IB, Grover JR, Soheilian F, Nagashima K, Ono A. Gag induces 
the coalescence of clustered lipid rafts and tetraspanin-enriched micro-
domains at HIV-1 assembly sites on the plasma membrane. J Virol (2011) 
85(19):9749–66. doi:10.1128/JVI.00743-11 
28. Yoshida T, Ebina H, Koyanagi Y. N-linked glycan-dependent interaction 
of CD63 with CXCR4 at the Golgi apparatus induces downregulation of 
CXCR4. Microbiol Immunol (2009) 53(11):629–35. doi:10.1111/j.1348-0421. 
2009.00167.x 
29. Yoshida T, Kawano Y, Sato K, Ando Y, Aoki J, Miura Y, et  al. A CD63 
mutant inhibits T-cell tropic human immunodeficiency virus type 1 entry 
by disrupting CXCR4 trafficking to the plasma membrane. Traffic (2008) 
9(4):540–58. doi:10.1111/j.1600-0854.2008.00700.x 
30. Yoshida N, Kitayama D, Arima M, Sakamoto A, Inamine A, Watanabe-
Takano H, et al. CXCR4 expression on activated B cells is downregulated 
by CD63 and IL-21. J Immunol (2011) 186(5):2800–8. doi:10.4049/
jimmunol.1003401 
31. Rocha-Perugini V, Gordon-Alonso M, Sanchez-Madrid F. PIP2: chore-
ographer of actin-adaptor proteins in the HIV-1 dance. Trends Microbiol 
(2014) 22(7):379–88. doi:10.1016/j.tim.2014.03.009 
32. Menager MM, Littman DR. Actin dynamics regulates dendritic cell- 
mediated transfer of HIV-1 to T  cells. Cell (2016) 164(4):695–709. 
doi:10.1016/j.cell.2015.12.036 
33. Menager MM. TSPAN7, effector of actin nucleation required for dendritic 
cell-mediated transfer of HIV-1 to T  cells. Biochem Soc Trans (2017) 
45(3):703–8. doi:10.1042/BST20160439 
34. Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, et  al. LIM kinase 1 
modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to 
initiate viral infection. J Biol Chem (2011) 286(14):12554–64. doi:10.1074/
jbc.M110.182238 
35. Jiménez-Baranda S, Gómez-Moutón C, Rojas A, Martínez-Prats L, Mira E, 
Ana Lacalle R, et al. Filamin-A regulates actin-dependent clustering of HIV 
receptors. Nat Cell Biol (2007) 9(7):838–46. doi:10.1038/ncb1610 
36. Rocha-Perugini V, Sanchez-Madrid F, Martinez Del Hoyo G. Function 
and dynamics of tetraspanins during antigen recognition and immunological syn-
apse formation. Front Immunol (2015) 6:653.doi:10.3389/fimmu.2015.00653
37. Liu WM, Zhang F, Moshiach S, Zhou B, Huang C, Srinivasan K, et  al. 
Tetraspanin CD82 inhibits protrusion and retraction in cell movement by 
attenuating the plasma membrane-dependent actin organization. PLoS 
One (2012) 7(12):e51797. doi:10.1371/journal.pone.0051797 
38. Tejera E, Rocha-Perugini V, López-Martín S, Pérez-Hernández D, Bachir AI, 
Horwitz AR, et  al. CD81 regulates cell migration through its association 
with Rac GTPase. Mol Biol Cell (2013) 24(3):261–73. doi:10.1091/mbc.
E12-09-0642 
39. Fievet BT, Gautreau A, Roy C, Del Maestro L, Mangeat P, Louvard D, et al. 
Phosphoinositide binding and phosphorylation act sequentially in the 
activation mechanism of ezrin. J Cell Biol (2004) 164(5):653–9. doi:10.1083/
jcb.200307032 
40. Barrero-Villar M, Cabrero JR, Gordón-Alonso M, Barroso-González J, 
Alvarez-Losada S, Muñoz-Fernández MA, et  al. Moesin is required for 
HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, mem-
brane fusion and viral infection in lymphocytes. J Cell Sci (2009) 122(Pt 1): 
103–13. doi:10.1242/jcs.035873 
41. Capalbo G, Mueller-Kuller T, Markovic S, Klein SA, Dietrich U, Hoelzer D, 
et  al. Knockdown of ERM family member moesin in host cells increases 
HIV type 1 replication. AIDS Res Hum Retroviruses (2011) 27(12):1317–22. 
doi:10.1089/aid.2010.0147 
42. Naghavi MH, Valente S, Hatziioannou T, de Los Santos K, Wen Y, Mott C, 
et  al. Moesin regulates stable microtubule formation and limits retroviral 
infection in cultured cells. EMBO J (2007) 26(1):41–52. doi:10.1038/sj.emboj. 
7601475 
43. Haedicke J, de Los Santos K, Goff SP, Naghavi MH. The Ezrin-radixin-
moesin family member ezrin regulates stable microtubule formation and 
retroviral infection. J Virol (2008) 82(9):4665–70. doi:10.1128/JVI.02403-07 
44. Sala-Valdés M, Ursa A, Charrin S, Rubinstein E, Hemler ME, Sánchez-
Madrid F, et al. EWI-2 and EWI-F link the tetraspanin web to the actin 
8Suárez et al. Tetraspanins in HIV-1 Replication
Frontiers in Immunology | www.frontiersin.org August 2018 | Volume 9 | Article 1811
cytoskeleton through their direct association with ezrin-radixin-moesin 
proteins. J Biol Chem (2006) 281(28):19665–75. doi:10.1074/jbc.
M602116200 
45. Corgan AM, Singleton C, Santoso CB, Greenwood JA. Phosphoinositi des 
differentially regulate alpha-actinin flexibility and function. Biochem J 
(2004) 378(Pt 3):1067–72. doi:10.1042/bj20031124 
46. Gordón-Alonso M, Sala-Valdés M, Rocha-Perugini V, Pérez-Hernández D, 
López-Martín S, Ursa A, et al. EWI-2 association with alpha-actinin regulates 
T cell immune synapses and HIV viral infection. J Immunol (2012) 189(2): 
689–700. doi:10.4049/jimmunol.1103708 
47. Gordón-Alonso M, Rocha-Perugini V, Álvarez S, Ursa Á, Izquierdo-Useros N, 
Martinez-Picado J, et  al. Actin-binding protein drebrin regulates HIV-
1-triggered actin polymerization and viral infection. J Biol Chem (2013) 
288(39):28382–97. doi:10.1074/jbc.M113.494906 
48. Yoder A, Yu D, Dong L, Iyer SR, Xu X, Kelly J, et al. HIV envelope-CXCR4 
signaling activates cofilin to overcome cortical actin restriction in resting 
CD4 T cells. Cell (2008) 134(5):782–92. doi:10.1016/j.cell.2008.06.036 
49. García-Expósito L, Ziglio S, Barroso-González J, de Armas-Rillo L, 
Valera MS, Zipeto D, et al. Gelsolin activity controls efficient early HIV-1 
infection. Retrovirology (2013) 10:39. doi:10.1186/1742-4690-10-39 
50. Gaudin R, de Alencar BC, Arhel N, Benaroch P. HIV trafficking in host 
cells: motors wanted! Trends Cell Biol (2013) 23(12):652–62. doi:10.1016/j.
tcb.2013.09.004 
51. Lukic Z, Dharan A, Fricke T, Diaz-Griffero F, Campbell EM. HIV-1 
uncoating is facilitated by dynein and kinesin 1. J Virol (2014) 88(23): 
13613–25. doi:10.1128/JVI.02219-14 
52. Izquierdo-Useros N, Blanco J, Erkizia I, Fernández-Figueras MT, Borràs FE, 
Naranjo-Gómez M, et  al. Maturation of blood-derived dendritic cells 
enhances human immunodeficiency virus type 1 capture and transmission. 
J Virol (2007) 81(14):7559–70. doi:10.1128/JVI.02572-06 
53. Yu HJ, Reuter MA, McDonald D. HIV traffics through a specialized, surface- 
accessible intracellular compartment during trans-infection of T  cells by 
mature dendritic cells. PLoS Pathog (2008) 4(8):e1000134. doi:10.1371/
journal.ppat.1000134 
54. Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes 
can mediate HIV-1 trans infection. Proc Natl Acad Sci U S A (2006) 
103(3):738–43. doi:10.1073/pnas.0507995103 
55. Izquierdo-Useros N, Naranjo-Gómez M, Erkizia I, Puertas MC, Borràs FE, 
Blanco J, et  al. HIV and mature dendritic cells: Trojan exosomes riding 
the Trojan horse? PLoS Pathog (2010) 6(3):e1000740. doi:10.1371/journal.
ppat.1000740 
56. Kulkarni R, Prasad A. Exosomes derived from HIV-1 infected DCs 
mediate viral trans-infection via fibronectin and galectin-3. Sci Rep (2017) 
7(1):14787. doi:10.1038/s41598-017-14817-8 
57. Garcia JV, Alfano J, Miller AD. The negative effect of human immunodefi-
ciency virus type 1 Nef on cell surface CD4 expression is not species spe-
cific and requires the cytoplasmic domain of CD4. J Virol (1993) 67(3):1511–6. 
58. Grzesiek S, Stahl SJ, Wingfield PT, Bax A. The CD4 determinant for down-
regulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding 
surface by NMR. Biochemistry (1996) 35(32):10256–61. doi:10.1021/
bi9611164 
59. Ren X, Park SY, Bonifacino JS, Hurley JH. How HIV-1 Nef hijacks the AP-2 
clathrin adaptor to downregulate CD4. Elife (2014) 3:e01754. doi:10.7554/
eLife.01754 
60. Dirk BS, Pawlak EN, Johnson AL, Van Nynatten LR, Jacob RA, Heit B, et al. 
HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of 
endocytosis and recycling. Sci Rep (2016) 6:37021. doi:10.1038/srep37021 
61. Sugden SM, Bego MG, Pham TN, Cohen ÉA. Remodeling of the host cell 
plasma membrane by HIV-1 Nef and Vpu: a strategy to ensure viral fitness 
and persistence. Viruses (2016) 8(3):67. doi:10.3390/v8030067 
62. Sato K, Aoki J, Misawa N, Daikoku E, Sano K, Tanaka Y, et al. Modulation of 
human immunodeficiency virus type 1 infectivity through incorporation of 
tetraspanin proteins. J Virol (2008) 82(2):1021–33. doi:10.1128/JVI.01044-07 
63. Haller C, Müller B, Fritz JV, Lamas-Murua M, Stolp B, Pujol FM, et  al.  
HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators 
of cell surface receptors, including tetraspanins. J Virol (2014) 88(24): 
14241–57. doi:10.1128/JVI.02333-14 
64. Lambelé M, Koppensteiner H, Symeonides M, Roy NH, Chan J, Schindler M, 
et al. Vpu is the main determinant for tetraspanin downregulation in HIV-1-
infected cells. J Virol (2015) 89(6):3247–55. doi:10.1128/JVI.03719-14 
65. Meroni L, Milazzo L, Menzaghi B, Mazzucchelli R, Mologni D, Morelli 
P, et  al. Altered expression of the tetraspanin CD81 on B and T  lympho-
cytes during HIV-1 infection. Clin Exp Immunol (2007) 147(1):53–9. 
doi:10.1111/j.1365-2249.2006.03250.x
66. Sundquist WI, Krausslich HG. HIV-1 assembly, budding, and maturation. 
Cold Spring Harb Perspect Med (2012) 2(7):a006924. doi:10.1101/cshperspect. 
a006924 
67. Murakami T. Roles of the interactions between Env and Gag proteins 
in the HIV-1 replication cycle. Microbiol Immunol (2008) 52(5):287–95. 
doi:10.1111/j.1348-0421.2008.00008.x 
68. Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 assembly, 
budding, and cell-cell spread in T cells take place in tetraspanin-enriched 
plasma membrane domains. J Virol (2007) 81(15):7873–84. doi:10.1128/
JVI.01845-06 
69. Nydegger S, Khurana S, Krementsov DN, Foti M, Thali M. Mapping of 
tetraspanin-enriched microdomains that can function as gateways for 
HIV-1. J Cell Biol (2006) 173(5):795–807. doi:10.1083/jcb.200508165 
70. Freed EO. HIV-1 assembly, release and maturation. Nat Rev Microbiol (2015) 
13(8):484–96. doi:10.1038/nrmicro3490 
71. Grigorov B, Attuil-Audenis V, Perugi F, Nedelec M, Watson S, Pique C, et al.  
A role for CD81 on the late steps of HIV-1 replication in a chronically 
infected T cell line. Retrovirology (2009) 6:28. doi:10.1186/1742-4690-6-28 
72. Ruiz-Mateos E, Pelchen-Matthews A, Deneka M, Marsh M. CD63 is not 
required for production of infectious human immunodeficiency virus 
type 1 in human macrophages. J Virol (2008) 82(10):4751–61. doi:10.1128/
JVI.02320-07 
73. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. 
In macrophages, HIV-1 assembles into an intracellular plasma membrane 
domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol (2007) 
177(2):329–41. doi:10.1083/jcb.200609050 
74. Pelchen-Matthews A, Giese S, Mlčochová P, Turner J, Marsh M β2 
integrin adhesion complexes maintain the integrity of HIV-1 assembly 
compartments in primary macrophages. Traffic (2012) 13(2):273–91. 
doi:10.1111/j.1600-0854.2011.01306.x 
75. Marsh M, Theusner K, Pelchen-Matthews A. HIV assembly and budding 
in macrophages. Biochem Soc Trans (2009) 37(Pt 1):185–9. doi:10.1042/
BST0370185 
76. Fassati A. Multiple roles of the capsid protein in the early steps of HIV-1 
infection. Virus Res (2012) 170(1–2):15–24. doi:10.1016/j.virusres.2012. 
09.012 
77. Campbell EM, Hope TJ. HIV-1 capsid: the multifaceted key player in 
HIV-1 infection. Nat Rev Microbiol (2015) 13(8):471–83. doi:10.1038/
nrmicro3503 
78. Jayappa KD, Ao Z, Yao X. The HIV-1 passage from cytoplasm to nucleus: the 
process involving a complex exchange between the components of HIV-1 
and cellular machinery to access nucleus and successful integration. Int 
J Biochem Mol Biol (2012) 3(1):70–85. 
79. Endsley MA, Somasunderam AD, Li G, Oezguen N, Thiviyanathan V, 
Murray JL, et al. Nuclear trafficking of the HIV-1 pre-integration complex 
depends on the ADAM10 intracellular domain. Virology (2014) 45(4–455): 
60–6. doi:10.1016/j.virol.2014.02.006 
80. Matthews AL, Szyroka J, Collier R, Noy PJ, Tomlinson MG. Scissor sisters: 
regulation of ADAM10 by the TspanC8 tetraspanins. Biochem Soc Trans 
(2017) 45(3):719–30. doi:10.1042/BST20160290 
81. Arhel N. Revisiting HIV-1 uncoating. Retrovirology (2010) 7:96. 
doi:10.1186/1742-4690-7-96 
82. Hilditch L, Towers GJ. A model for cofactor use during HIV-1 reverse tran-
scription and nuclear entry. Curr Opin Virol (2014) 4:32–6. doi:10.1016/j.
coviro.2013.11.003 
83. Iordanskiy S, Bukrinsky M. Reverse transcription complex: the key player 
of the early phase of HIV replication. Future Virol (2007) 2(1):49–64. 
doi:10.2217/17460794.2.1.49 
84. Li G, Dziuba N, Friedrich B, Murray JL, Ferguson MR. A post-entry role 
for CD63 in early HIV-1 replication. Virology (2011) 412(2):315–24. 
doi:10.1016/j.virol.2011.01.017 
85. Fu E, Pan L, Xie Y, Mu D, Liu W, Jin F, et al. Tetraspanin CD63 is a regulator 
of HIV-1 replication. Int J Clin Exp Pathol (2015) 8(2):1184–98. 
86. Li G, Endsley MA, Somasunderam A, Gbota SL, Mbaka MI, Murray JL, et al. 
The dual role of tetraspanin CD63 in HIV-1 replication. Virol J (2014) 11:23. 
doi:10.1186/1743-422X-11-23 
9Suárez et al. Tetraspanins in HIV-1 Replication
Frontiers in Immunology | www.frontiersin.org August 2018 | Volume 9 | Article 1811
87. Rocha-Perugini V, Suárez H, Álvarez S, López-Martín S, Lenzi GM, 
Vences-Catalán F, et al. CD81 association with SAMHD1 enhances HIV-1 
reverse transcription by increasing dNTP levels. Nat Microbiol (2017) 
2(11):1513–22. doi:10.1038/s41564-017-0019-0 
88. Franzolin E, Pontarin G, Rampazzo C, Miazzi C, Ferraro P, Palumbo E, 
et  al. The deoxynucleotide triphosphohydrolase SAMHD1 is a major 
regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci 
U S A (2013) 110(35):14272–7. doi:10.1073/pnas.1312033110 
89. Daddacha W, Koyen AE, Bastien AJ, Head PE, Dhere VR, Nabeta GN, 
et  al. SAMHD1 promotes DNA end resection to facilitate DNA repair by 
homologous recombination. Cell Rep (2017) 20(8):1921–35. doi:10.1016/j.
celrep.2017.08.008 
90. Cabello-Lobato MJ, Wang S, Schmidt CK. SAMHD1 sheds moonlight 
on DNA double-strand break repair. Trends Genet (2017) 33(12):895–7. 
doi:10.1016/j.tig.2017.09.007 
91. Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim SY, et al. The ribonuclease activity 
of SAMHD1 is required for HIV-1 restriction. Nat Med (2014) 20(8):936–41. 
doi:10.1038/nm.3626 
92. Welbourn S, Strebel K. Low dNTP levels are necessary but may not be 
sufficient for lentiviral restriction by SAMHD1. Virology (2016) 488:271–7. 
doi:10.1016/j.virol.2015.11.022 
93. Ballana E, Este JA. SAMHD1: at the crossroads of cell proliferation, immune 
responses, and virus restriction. Trends Microbiol (2015) 23(11):680–92. 
doi:10.1016/j.tim.2015.08.002 
94. Hansen EC, Seamon KJ, Cravens SL, Stivers JT. GTP activator and dNTP 
substrates of HIV-1 restriction factor SAMHD1 generate a long-lived acti-
vated state. Proc Natl Acad Sci U S A (2014) 111(18):E1843–51. doi:10.1073/
pnas.1401706111 
95. Cribier A, Descours B, Valadão AL, Laguette N, Benkirane M. Phosphorylation 
of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward 
HIV-1. Cell Rep (2013) 3(4):1036–43. doi:10.1016/j.celrep.2013.03.017 
96. Coiras M, Bermejo M, Descours B, Mateos E, García-Pérez J, López-
Huertas MR, et  al. IL-7 induces SAMHD1 phosphorylation in CD4+ 
T  lymphocytes, improving early steps of HIV-1 life cycle. Cell Rep (2016) 
14(9):2100–7. doi:10.1016/j.celrep.2016.02.022 
97. Lee EJ, Seo JH, Park JH, Vo TTL, An S, Bae SJ, et al. SAMHD1 acetylation 
enhances its deoxynucleotide triphosphohydrolase activity and promotes 
cancer cell proliferation. Oncotarget (2017) 8(40):68517–29. doi:10.18632/
oncotarget.19704 
98. Mauney CH, Rogers LC, Harris RS, Daniel LW, Devarie-Baez NO, Wu H, 
et  al. The SAMHD1 dNTP triphosphohydrolase is controlled by a redox 
switch. Antioxid Redox Signal (2017) 27(16):1317–31. doi:10.1089/ars. 
2016.6888 
99. Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, et al. 
SAMHD1 restricts HIV-1 infection in resting CD4(+) T  cells. Nat Med 
(2012) 18(11):1682–7. doi:10.1038/nm.2964 
100. Brandariz-Nuñez A, Valle-Casuso JC, White TE, Laguette N, Benkirane M, 
Brojatsch J, et  al. Role of SAMHD1 nuclear localization in restriction 
of HIV-1 and SIVmac. Retrovirology (2012) 9:49. doi:10.1186/1742- 
4690-9-49 
101. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, 
et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction 
factor counteracted by Vpx. Nature (2011) 474(7353):654–7. doi:10.1038/
nature10117 
102. Bruner KM, Hosmane NN, Siliciano RF. Towards an HIV-1 cure: measuring 
the latent reservoir. Trends Microbiol (2015) 23(4):192–203. doi:10.1016/j.
tim.2015.01.013 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2018 Suárez, Rocha-Perugini, Álvarez and Yáñez-Mó. This is an 
open-access article distributed under the terms of the Creative Commons Attribution 
License (CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) and the copyright owner(s) are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
